{"id":"W2889905232","doi":"10.1182/bloodadvances.2018015677","title":"A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Juravinski Hospital; London Health Sciences Centre; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Cytarabine; Medicine; Tolerability; Myeloid leukemia; Internal medicine; Acute leukemia; Refractory (planetary science); Pharmacology; Oncology; Leukemia; Adverse effect; Gastroenterology; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001060834,0.000812947,0.00120262,0.0002611659,0.0003111873,0.0004987215,0.0004866384,0.0006643387,0.001544977],"category_scores_gemma":[0.0006821533,0.0003022406,0.0007263996,0.0002545942,0.0004239987,0.0003552718,0.0002258894,0.001704715,0.0003846404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004996386,"about_ca_system_score_gemma":0.0008785144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005056317,"about_ca_topic_score_gemma":0.001916434,"domain_scores_codex":[0.9996663,0.0001953287,0.00001613049,0.00005287031,0.00002802995,0.00004132536],"domain_scores_gemma":[0.9996219,0.00007060852,0.0001020054,0.00002900981,0.00002443826,0.0001520183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5188707,0.0422711,0.01486908,0.001422381,0.001517838,0.0007082465,0.0006014904,0.00490238,0.1179635,0.0005062459,0.003436951,0.2929301],"study_design_scores_gemma":[0.4083665,0.5662467,0.01294508,0.00004247962,0.000383494,0.0004224729,0.0000475555,0.001520452,0.005244162,0.0002002595,0.004556972,0.00002367456],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942878,0.002556656,0.0004568321,0.0003191518,0.00006076347,0.001331867,0.0003053033,0.00003967772,0.0006419665],"genre_scores_gemma":[0.9913585,0.002432143,0.001964483,0.0005315118,0.0001219537,0.001515661,0.000947356,0.00001344109,0.001114978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001544977,"threshold_uncertainty_score":0.005610287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01813438728361201,"score_gpt":0.3399382594057945,"score_spread":0.3218038721221825,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}